Achieve Life Sciences Inc (NASDAQ: ACHV) kicked off on Monday, up 18.53% from the previous trading day, before settling in for the closing price of $2.32. Over the past 52 weeks, ACHV has traded in a range of $1.84-$5.31.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Annual sales at Healthcare sector company grew by 50.01% over the past five years. While this was happening, its average annual earnings per share was recorded 1.94%. With a float of $42.08 million, this company’s outstanding shares have now reached $49.69 million.
Let’s look at the performance matrix of the company that is accounted for 25 employees. In terms of profitability, gross margin is 0.0%, operating margin of 0.0%, and the pretax margin is 0.0%.
Achieve Life Sciences Inc (ACHV) Insider and Institutional Ownership
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Achieve Life Sciences Inc is 15.32%, while institutional ownership is 31.66%. The most recent insider transaction that took place on Mar 17 ’25, was worth 28,887. In this transaction Chief Financial Officer of this company bought 10,000 shares at a rate of $2.89, taking the stock ownership to the 10,000 shares. Before that another transaction happened on Mar 17 ’25, when Company’s Chieve Executive Officer bought 10,000 for $2.86, making the entire transaction worth $28,598. This insider now owns 60,876 shares in total.
Achieve Life Sciences Inc (ACHV) Latest Financial update
According to the Wall Street analysts, stocks earnings will be around 1.94% per share during the next fiscal year.
Achieve Life Sciences Inc (NASDAQ: ACHV) Trading Performance Indicators
Take a look at Achieve Life Sciences Inc’s (ACHV) current performance indicators. Last quarter, stock had a quick ratio of 3.51.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.34, a number that is poised to hit -0.37 in the next quarter and is forecasted to reach -1.08 in one year’s time.
Technical Analysis of Achieve Life Sciences Inc (ACHV)
Achieve Life Sciences Inc (NASDAQ: ACHV) saw its 5-day average volume 2.01 million, a positive change from its year-to-date volume of 0.47 million. As of the previous 9 days, the stock’s Stochastic %D was 74.06%.
During the past 100 days, Achieve Life Sciences Inc’s (ACHV) raw stochastic average was set at 36.99%, which indicates a significant decrease from 39.47% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.23 in the past 14 days, which was higher than the 0.23 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $2.99, while its 200-day Moving Average is $3.48. Nevertheless, the first resistance level for the watch stands at $2.90 in the near term. At $3.05, the stock is likely to face the second major resistance level. The third major resistance level sits at $3.27. If the price goes on to break the first support level at $2.53, it is likely to go to the next support level at $2.31. The third support level lies at $2.16 if the price breaches the second support level.
Achieve Life Sciences Inc (NASDAQ: ACHV) Key Stats
The company with the Market Capitalisation of 136.63 million has total of 34,685K Shares Outstanding. Its annual sales at the moment are 0 K in contrast with the sum of -39,830 K annual income. Company’s last quarter sales were recorded 0 K and last quarter income was -12,830 K.
